Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma.
Ye Y, Scheff NN, Bernabé D, Salvo E, Ono K, Liu C, Veeramachaneni R, Viet CT, Viet DT, Dolan JC, Schmidt BL.
Ye Y, et al. Among authors: liu c.
Neuropharmacology. 2018 Sep 1;139:182-193. doi: 10.1016/j.neuropharm.2018.07.016. Epub 2018 Jul 20.
Neuropharmacology. 2018.
PMID: 30009833